Marrone bio's inventory line of credit increased to support sales and manufacturing growth

Raleigh, n.c., jan. 06, 2022 (globe newswire) -- marrone bio innovations, inc. (nasdaq: mbii) has expanded its existing inventory line of credit to support the company's expectations for growth in sales and manufacturing capacity. under an amended agreement with lsq funding group, l.c., the company can access a maximum of $4.5 million to finance inventory needs, up from $3 million under a prior agreement.
MBII Ratings Summary
MBII Quant Ranking